{
  "id": 17792677,
  "title": "Should You Invest $1,000 in BridgeBio Pharma Right Now?",
  "url": "https://urgent.news/2026/11/02/should-you-invest-1-000-in-bridgebio-pharma-right-now",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-02T11:45:00.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/investing/2026/11/02/should-you-invest-1000-in-bridgebio-pharma-now/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": null,
  "summary": "The pharmaceutical company has only two approved therapies, but others should be on the way soon.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Nasdaq Markets",
        "title": "Should You Invest $1,000 in BridgeBio Pharma Right Now?",
        "url": "https://urgent.news/2026/11/02/should-you-invest-1-000-in-bridgebio-pharma-right-now-17793807",
        "published": "2026-11-02T12:05:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}